Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Semen Indonesia (Persero) Tbk Buy (bullish), based on 11 analysts. Average price target: IDR 2,397.91.
Top signal score 37 of 100
Buys €478,063€4,116 Sells
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 15,270 of 26,248 companies
46.6
score / 100
Value
67
Quality
26
FCF yld30%
Earn yld2.2%
EV/EBITDA9.3x
ROE0.7%
Gross mgn20%
Net mgn0.5%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
24,500 shares@ IDR 3,950.004.3% of flowIDXIDX:3224-KS.10-SPT-50056838-2000-05.2024-SMGR#3
Canonical exit: 20 Aug 2024 (T+90)
14 of 14 declarations
About Semen Indonesia (Persero) Tbk
On October 1, 2024, 9 insiders of Semen Indonesia (Persero) Tbk (chemicals, Indonesia Stock Exchange) bought together for EUR 420,284. The largest purchases of the day are by Donny Arsal, Direksi, with EUR 71,783, then Andriano Hosny Panangian and Yosviandri, both Direksi, with EUR 61,040 each. Across the whole record, 13 purchases total EUR 478,063, with a median of EUR 29,074.
Only one sale appears: EUR 4,116 by Sony Subrata, Dewan Komisaris, on January 30, 2025. Donny Arsal is the most active with 5 filings, all purchases.
Read moreShow less
The record is short: 14 filings, 13 in 2024 and 1 in 2025, published between May 27, 2024 and March 10, 2025, with a median delay of 7 days. None falls in the last twelve months. The 9 insiders hold 55.9% of a market capitalisation of IDR 8,655.2 billion. For 13 purchases a 90-day result is stored: a median of -20.7%, 31% of results positive, recorded past results and not a forecast.